Rare diseases plan for France due in 2009

19 October 2008

France's President Nicolas Sarkozy has announced the formulation of a new plan in 2009 for orphan or rare diseases, to be effective in 2010. The proposal would continue the work of a previous government initiative, the First Rare Diseases Plan, which aimed to improve both scientific knowledge about pathogens that affect fewer than five per 10,000 European Union citizens, as well as the care of patients with these conditions.

Pres Sarkozy, who also holds the EU's rotating presidency, said he hopes "that the communication from the [European] Commission on the treatment of the 30 million Europeans affected by a rare disease should be one of the priorities of the French presidency of the EU in the domain of health care."

LEEM: France could be Europe's laboratory

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight